Ss. Soldan et al., HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease, J INFEC DIS, 180(3), 1999, pp. 685-694
The human T-cell lymphotropic virus type I(HTLV-I) is associated with a chr
onic, progressive neurological disease known as HTLV-I-associated myelopath
y/tropical spastic paraparesis, Screening for HTLV-I involves the detection
of virus-specific serum antibodies by EIA and confirmation by Western blot
. HTLV-I/II seroindeterminate Western blot patterns have been described wor
ldwide. However, the significance of this blot pattern is unclear. We ident
ified 8 patients with neurological disease and an HTLV-I/II seroindetermina
te Western blot pattern, none of whom demonstrated increased spontaneous pr
oliferation and HTLVI-specific cytotoxic T lymphocyte activity. However, HT
LV-I tax sequence was amplified from the peripheral blood lymphocytes of 4
of them. These data suggest that patients with chronic progressive neurolog
ical disease and HTLV-I/II Western blot seroindeterminate reactivity may ha
rbor either defective HTLV-I, novel retrovirus with partial homology to HTL
V-I, or HTLVI in low copy number.